Task: Answer the multiple-choice question.
Question: Which drug exhibits a -27.042% human ether-à-go-go related gene (hERG) inhibition at 10uM?
Constraint: You must select none, one or more options from a, b, or c without using any other words.
Options:
a. Cc1ccccc1N1CCN(CC(=O)NCc2ccc(Cl)cc2)CC1
b. CCC12CN3CC(CC)(CN(C1)C3c1cccnc1)C2=O
c. CN(Cc1cc([N+](=O)[O-])c2cccnc2c1O)C1CCCCC1
Answer: a. Cc1ccccc1N1CCN(CC(=O)NCc2ccc(Cl)cc2)CC1
{#Task|Problem statement!}: Answer the {#multiple choice|multiple-choice|MCQ!} question.
{#Question|Query!}: Which {#compound|drug!} {#has|exhibits!} a {herg_central_at_10uM#}{herg_central_at_10uM__units} {herg_central_at_10uM__names__noun}?
Constraint: You must select none, one or more options from {%multiple_choice_enum%2-5%aA1} without using any {#other|additional!} words.
Options:
{SMILES%herg_central_at_10uM%}
Answer: {%multiple_choice_result}. {SMILES#}
Cc1ccccc1N1CCN(CC(=O)NCc2ccc(Cl)cc2)CC1
Cc1ccccc1N1CCN(CC(=O)NCc2ccc(Cl)cc2)CC1
N-[(4-chlorophenyl)methyl]-2-[4-(2-methylphenyl)piperazin-1-yl]acetamide